
    
      Primary objectives

        1. To identify the factors associated with the development of hyponatremia in patients
           receiving high-dose cyclophosphamide (2.5 grams or more).

        2. Generate and validate a predictive score of developing hyponatremia high-dose
           cyclophosphamide.

        3. To estimate the incidence of hyponatremia in patients undergoing high-dose
           cyclophosphamide.

      Study design. Observational prospective cohort study of Patients after infusion of high-dose
      cyclophosphamide. Follow up period will be from cyclophosphamide infusion until one month
      after hospital discharge.
    
  